Literature DB >> 18937111

Predominance of activated EGFR higher-order oligomers on the cell surface.

Andrew H A Clayton1, Suzanne G Orchard, Edouard C Nice, Richard G Posner, Antony W Burgess.   

Abstract

The epidermal growth factor receptor (EGFR) kinase is generally considered to be activated by either ligand-induced dimerisation or a ligand-induced conformational change within pre-formed dimers. We report the relationship between ligand-induced higher-order EGFR oligomerization and EGFR phosphorylation on the surface of intact cells. We have combined lifetime-detected Forster resonance energy transfer, as a probe of the receptor phosphorylation state and image correlation spectroscopy, to extract the relative association state of activated versus unactivated EGFR, to determine the ratio of the average number of receptors for active (phosphorylated) and inactive clusters. There are at least four times as many receptors in the ligand-induced active clusters than inactive clusters. Contrary to the prevailing view that the EGFR dimer is the predominant, active form, our data determine that higher-order EGFR oligomers are the dominant species associated with the ligand activated EGFR tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18937111     DOI: 10.1080/08977190802442187

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  41 in total

1.  Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis.

Authors:  Peter Nagy; Jeroen Claus; Thomas M Jovin; Donna J Arndt-Jovin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-02       Impact factor: 11.205

Review 2.  The linker for activation of T cells (LAT) signaling hub: from signaling complexes to microclusters.

Authors:  Lakshmi Balagopalan; Robert L Kortum; Nathan P Coussens; Valarie A Barr; Lawrence E Samelson
Journal:  J Biol Chem       Date:  2015-09-09       Impact factor: 5.157

3.  Nanoconjugation: A Materials Approach to Enhance Epidermal Growth Factor Induced Apoptosis.

Authors:  Linxi Wu; Xinwei Yu; Amin Feizpour; Björn M Reinhard
Journal:  Biomater Sci       Date:  2014-02-01       Impact factor: 6.843

4.  The FRET signatures of noninteracting proteins in membranes: simulations and experiments.

Authors:  Christopher King; Sarvenaz Sarabipour; Patrick Byrne; Daniel J Leahy; Kalina Hristova
Journal:  Biophys J       Date:  2014-03-18       Impact factor: 4.033

5.  Organization of higher-order oligomers of the serotonin₁(A) receptor explored utilizing homo-FRET in live cells.

Authors:  Sourav Ganguly; Andrew H A Clayton; Amitabha Chattopadhyay
Journal:  Biophys J       Date:  2011-01-19       Impact factor: 4.033

6.  Nanopore-mediated protein delivery enabling three-color single-molecule tracking in living cells.

Authors:  Zhongwen Chen; Yuhong Cao; Chun-Wei Lin; Steven Alvarez; Dongmyung Oh; Peidong Yang; Jay T Groves
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

Review 7.  Fluorescence-based approaches for monitoring membrane receptor oligomerization.

Authors:  Andrew Ha Clayton
Journal:  J Biosci       Date:  2018-07       Impact factor: 1.826

8.  A new temperature-dependent strategy to modulate the epidermal growth factor receptor.

Authors:  Zhe Li; David R Tyrpak; Mincheol Park; Curtis T Okamoto; J Andrew MacKay
Journal:  Biomaterials       Date:  2018-08-11       Impact factor: 12.479

9.  Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling.

Authors:  Qian Zhang; Euisun Park; Kian Kani; Ralf Landgraf
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

Review 10.  A structural perspective on the regulation of the epidermal growth factor receptor.

Authors:  Erika Kovacs; Julie Anne Zorn; Yongjian Huang; Tiago Barros; John Kuriyan
Journal:  Annu Rev Biochem       Date:  2015-01-26       Impact factor: 23.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.